BSEResult13 Aug 2026 · 13 Aug 2026, 06:03 pm

Please refer to the attached annexure.

Kothari Fermentation & Biochem Ltd · 507474

✦ AI SummaryResults

Kothari Fermentation & Biochem Ltd announced unaudited financial results for the quarter ended June 30, 2026, along with the re-appointment of Mr. Pramod Kumar Kothari as a director, subject to member approval. The company also announced the draft notice for convening the 36th Annual General Meeting on September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Kothari Fermentation & Biochem Ltd - 507474 - Unaudited Financial Results For The Quarter Ended June 30, 2026

Attachments (1)

📄

cf424860-353f-4a94-a785-52de9f575f34.pdf

pdf

Download →
View document text
KOTHARI FERMENTATION AND BIOCHEM LTD. An I1SO 22000 : 2018 & KOSHER Certified Company Regd. Office : 16, Community Centre, 1st Floor, Saket, New Delhi -110017 TEL.: +91 11 40590944 E-mail : info@kothariyeast.in Web : www.kothariyeast.in CIN : L72411DL1990PLC042502 August 13, 2026 The BSE Limited, Phiroz Jeejeebhoy Towers, 25" Floor, Dalal Street, Mumbai-400001 Ref: Scrip Code No. 507474 Subject: Outcome of Board Meeting held on August 13, 2026, pursuant to the provisions contained under Regulation 30, 33, and other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) Dear Sir/Madam, Pursuant to the provisions of Regulation 30, Regulation 33, and other applicable provisions of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (Listing Regulations), as amended from time to time, we hereby inform you that the Board of Directors of the Company at its meeting held today, i.e., Thursday, August 13, 2026, has considered and approved the following matters as mentioned below: 1. Unaudited Standalone Financial Results of the Company along with the Limited Review Report by the Statutory Auditor for the quarter ended June 30, 2026, and a copy of the same is also enclosed herewith in Annexure A. Further, the aforesaid Unaudited Standalone Financial Results of the Company are also sent for publication in the newspapers. 2. Based on the recommendation of the Nomination and Remuneration Committee, the re-appointment of Mr. Pramod Kumar Kothari (DIN: 00086145), who retires by rotation in terms of the provisions of Section 152(6) of the Companies Act, 2013, and being eligible, offers himself for re-appointment, subject to the approval of the members of the Company at the ensuing 36" Annual General Meeting (AGM). The details required under Regulation 30 of the Listing Regulations read with the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026, with respect to the director proposed to be re-appointed, shall be provided in the Notice of the 36™ Annual General Meeting of the Company. 3. Draft notice for convening the 36" AGM of the Company, which is scheduled to be held on Wednesday, September 30, 2026. The Notice of the AGM will be sent in due course and will be intimated separately. The meeting commenced at 02:30 PM and concluded at H:35pPM. Kindly take the same on record. Thanking you, Yours faithfully, FOR KOTHARI FERMENTATION & BIOCHEM LIMITED FACTORY : D 6-12, RAJARAMPUR, UPSIDC INDUSTRIAL AREA, SIKANDRABAD, DISTT. BULANDSHAHR (U.P.)-203206 S Annexure A KOTHARI KULDEEP & CO. CHARTERED ACCOUNTANTS Independent Auditor's Review Report on Quarterly and Year-to-Date Unaudited Financial Results of the Company Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended The Board of Directors Kothari Fermentation & Biochem Ltd 1st Floor, 16, Community Centre, Saket New Delhi -110017 i, We have Reviewed the accompanying Statement of Unaudited financial results ("the Statement") of Kothari Fermentation & Biochem Limited ("the Company") for the Quarter ended on 30.06.2026 attached herewith, being submitted by the Company pursuant to the requirement of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'). The Preparation of the statement in accordance with the recognition and measurement principles laid down in Indian Accounting Standards 34, (IND AS 34) "Interim Financial Reporting" Prescribed Under Section 133 of the Companies Act, 2013, as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India, read with the circular is the responsibility of the Company's management and has been approved by the Board of Directors of the company. Our responsibility is to issue a report on the Statement based on our review. We conducted our review of the statement in accordance with the Standard on Review Engagement (SRE) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Institute of Chartered Accountants of India. This Standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review is limited primarily to inquiries of company personnel and analytical procedures applied to financial data and thus provide less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. ® il eamkica@gmailcom 8 Phone: 7827817035 @ hdress: 31 loor, 10, Vigyan Vihar, Delhi- 110052 KOTHARI KULDEEP & CO. CHARTERED ACCOUNTANTS 4. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement has not been prepared in all material respects in accordance with Indian Accounting Standards ('IND AS') and other recognized accounting practices and policies, and has not disclosed the information required to be disclosed in terms of Listing Regulations, read with the circular, including the manner in which it is to be disclosed, or that it contains any material misstatement. For Kothari Kuldeep & Co (Chartered Accountants) Firm Registration No.: 015960C (Kuldeep Kothari) Partner Membership No.413714 Place: New Delhi Date: August 13, 2026 UDIN: 26413714MMZFFV7500 O Email: teamkkca@gmail.com 3 Phone: 7827817035 Q@ ress: 3¢ o, 10, Viyan iar, Deli- 110052 KOTHARI FERMENTATION AND BIOCHEM LIMITED REGD. OFFICE: 16, COMMUNITY CENTRE, 1ST FLOOR, SAKET, NEW DELHI - 110017 CIN : L72411DL1990PLC042502 Tel: 011-40590944, E-mai info@kothariyeast.in , Website: www.kothariyeast.in STATEMENT OF UN-AUDITED FINANCIAL RESULTS FOR QUARTER ENDED 30.06.2026 (Rs. in Lakhs Except EPS) Quarter ended Year ended Particulars 30.06.2026 31.03.2026 | 30.06.2025 31.03.2026 5.No. Unaudited Audited | Unaudited Audited 1| Income a. Revenue from operations 3,041.20 3,246.80 2,37531 11,213.19 b. Other Income 357 72.89 - 73.68 Total Income 3,044.77 3,319.69 2,375.31 11,286.87 2| Expenses (a) Cost of Materials consumed 1,539.94 142271 1,064.16 5,241.51 (b) Changes in inventories of finished goods, work-in progress (0.34) (37.97)] 2025 59.16 (c) Purchase of Traded Goods - 089 - 089 (d) Employees benefit expense 313.26 38262 27084 1,232.10 (e) Power & Fuel 623.43 801.46 536.70 2,695.25 (f) Finance Cost 91.32 108.80 7957 369.93 (g) Depreciation & amortization expense 174.07 17541 174.88 700.24 (h) Other expenses 299.80 385.81 317.61 1,334.02 Total expenses (a to h) 3,041.48 3,239.72 2,464.01 11,633.10 3| Profit/(loss) before exceptional items and tax 330 79.97 (88.70)| (346.23) 4|Exceptional Items (Net) - 5| Profit before Tax 330 79.97 (88.70) (346.23)| 6| Tax expense - Current Tax - - - Deferred Tax (3.16), (47.30)} 23.76 (47.30 7| Net Profit after tax for the period(5-6) 6.45 127.26 (112.46) (298.93), 8| Other Comprehensive Income (OCI) Items that will not be reclassified to profit or loss Rmeasurement of Defined Benefit Plans 1240 64.70 (5.03) 49.60 Tax Relating to measurement of Defined Benefit Plans 6.22) (17.10) 140 (12.90) 9| Other Comprehensive Income/(loss) for the period 9.18 47.60 (3.63), 36.71 10| Total Comprehensive Income 1563 174.86 (116.09) (262.22) 11 Paid up Equity Share Capital ( face value of Rs. 10/-each) 1,500 1,500 1,500 1,500 13. Earning Per share- In Rs. Basic (In Rs.)- Not annualized 004 085 (0.75) (1.99) Diluted ( In Rs.)- Not annualized 004 085 (0.75) (1.99) Notes: P 1. The Business activity of the company primarily falls in a single business segment viz Yeast’ and it has expanded into cattle feed product which has a strong synergy with the company’s core business. Considering the interlinked nature of the products, the resources are allocated actoss the company interchangeably and business performance is reviewed as one segm [Showing first 8,000 characters — download PDF for full document]